We are live on ! Find out more
DA

DCF Advisers Portfolio holdings

AUM $566M
1-Year Est. Return 197.74%
This Fund
S&P 500
This Quarter Est. Return
+96.59%
1 Year Est. Return
+197.74%
3 Year Est. Return
+371.51%
5 Year Est. Return
+473.27%
10 Year Est. Return
AUM
$566M
AUM Growth
+$191M
Cap. Flow
-$25.1M
Cap. Flow %
-4.43%
Top 10 Hldgs %
65.92%
Holding
98
New
12
Increased
27
Reduced
22
Closed
5

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$5.33M
2
HELP
Cybin Inc
HELP
+$3.72M
3
MSFT icon
Microsoft
MSFT
+$3.33M
4
IMRX icon
Immuneering
IMRX
+$3.28M
5
VRTX icon
Vertex Pharmaceuticals
VRTX
+$1.99M

Top Sells

Rank Stock Value
1
MU icon
Micron Technology
MU
+$37.5M
2
LLY icon
Eli Lilly
LLY
+$5.72M
3
CSCO icon
Cisco
CSCO
+$1.57M
4
TEVA icon
Teva Pharmaceuticals
TEVA
+$1.52M
5
IONS icon
Ionis Pharmaceuticals
IONS
+$1.39M

Sector Composition

Rank Sector Weight
1 Miscellaneous 38.15%
2 Technology 31.31%
3 Healthcare 17.63%
4 Communication Services 4.62%
5 Consumer Discretionary 4.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZM icon
26
Zoom
ZM
$27.9B
$4.39M 0.78%
50,875
+4,375
+9% +$414K
INTC icon
27
Intel
INTC
$544B
$3.98M 0.7%
28,500
-6,500
-19% -$657K
IMRX icon
28
Immuneering
IMRX
$276M
$3.94M 0.7%
790,000
+648,538
+458% +$3.28M
BABA icon
29
Alibaba
BABA
$272B
$3.79M 0.67%
39,500
+1,000
+3% +$125K
MSFT icon
30
Microsoft
MSFT
$3.68T
$3.63M 0.64%
9,725
+8,225
+548% +$3.33M
UBER icon
31
Uber
UBER
$146B
$3.61M 0.64%
50,000
-5,000
-9% -$367K
LRCX icon
32
Lam Research
LRCX
$373B
$3.25M 0.57%
7,500
LLY icon
33
Eli Lilly
LLY
$994B
$3.24M 0.57%
2,700
-5,600
-67% -$5.72M
EVO icon
34
Evotec
EVO
$615M
$3.02M 0.53%
1,079,024
+13,750
+1% +$39.7K
IONS icon
35
Ionis Pharmaceuticals
IONS
$9.01B
$2.97M 0.53%
37,500
-18,500
-33% -$1.39M
AOD
36
abrdn Total Dynamic Dividend Fund
AOD
$1.11B
$2.74M 0.48%
266,000
ABBV icon
37
AbbVie
ABBV
$454B
$2.71M 0.48%
10,750
AVGO icon
38
Broadcom
AVGO
$1.73T
$2.69M 0.48%
7,125
+2,250
+46% +$902K
ZBH icon
39
Zimmer Biomet
ZBH
$17.8B
$2.63M 0.46%
30,500
JQC icon
40
Nuveen Credit Strategies Income Fund
JQC
$696M
$2.57M 0.45%
528,113
+51,777
+11% +$250K
GDXJ icon
41
VanEck Junior Gold Miners ETF
GDXJ
$9.32B
$2.46M 0.43%
25,000
MSFT icon
42
CALL
Microsoft
MSFT
$3.68T
$2.31M 0.41%
6,200
+5,200
+520% +$2.1M
LFCR icon
43
Lifecore Biomedical
LFCR
$156M
$2.23M 0.39%
424,500
B
44
Barrick Mining
B
$71.9B
$2.2M 0.39%
60,000
SLV icon
45
iShares Silver Trust
SLV
$31.3B
$2.14M 0.38%
40,000
HZO icon
46
MarineMax
HZO
$1.15B
$2.11M 0.37%
+57,500
New +$1.85M
BNED icon
47
Barnes & Noble Education
BNED
$389M
$2.06M 0.36%
164,383
-32,560
-17% -$340K
BHVN icon
48
CALL
Biohaven
BHVN
$1.92B
$2M 0.35%
134,500
BHVN icon
49
Biohaven
BHVN
$1.92B
$1.93M 0.34%
130,000
+6,500
+5% +$70K
AMGN icon
50
Amgen
AMGN
$204B
$1.9M 0.34%
5,250
-750
-13% -$257K

Similar funds

DCF Advisers's Q2 2026 Portfolio in Review

As of Q2 2026, DCF Advisers held 98 positions worth $566M, up 51% from $375M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

DCF Advisers withdrew a net $25.1M in Q2 2026, closing 5 positions and reducing 22 holdings. Its most notable exit was Synopsys, an estimated $496K position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 38% of assets, down from 38% a quarter earlier, followed by Technology and Healthcare.

Against the trend, DCF Advisers opened a new position in MarineMax worth $2.11M.

  • DCF Advisers's largest Q2 2026 buy was MarineMax: 57,500 shares worth $2.11M.
  • DCF Advisers added most to Amazon in Q2 2026, an estimated $5.33M increase.
  • DCF Advisers's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $37.5M.
  • DCF Advisers fully exited Synopsys in Q2 2026, selling an estimated $496K.
  • DCF Advisers's ten largest holdings make up 66% of its $566M portfolio in Q2 2026.
  • DCF Advisers opened 12 new positions and closed 5 in Q2 2026.
  • DCF Advisers's portfolio value rose 51% quarter-over-quarter to $566M.

Based on DCF Advisers's 13F filing for Q2 2026, filed 10 Aug 2026.